SNTI insider filings

Senti Biosciences Holdings, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-23. Screen SNTI transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Lu Timothy K — CEO, Director1——1
Rajangam Kanya — Pres. & Chief Med. & Dev. Off.1——1

Recent insider filings — Senti Biosciences Holdings, Inc.

FiledFormInsiderReported transactionsSource
2026-10-234Lu Timothy K — CEO, DirectorTax withholding (F): 157,312 @ $0EDGAR
2026-10-234Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Tax withholding (F): 19,953 @ $0EDGAR
2026-03-114Lu Timothy K — CEO, DirectorTax withholding (F): 80,666 @ $0EDGAR
2026-03-114Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Tax withholding (F): 10,757 @ $0EDGAR
2026-02-034Lu Timothy K — CEO, DirectorTax withholding (F): 4,191 @ $0EDGAR
2026-02-034Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Tax withholding (F): 1,384 @ $0EDGAR
2025-07-214Baum Bryan Daniel — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-06-274Hsiung Feng — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-06-274Schulz Fran — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-06-274COOPERSTONE BRENDA — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-06-274Tang Donald F — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-06-274Collins James J. — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-06-274Mathers Edward T — DirectorGrant/award (A): 21,950 (derivative) @ $0EDGAR
2025-03-144Celadon Partners SPV 24 — 10% ownerConversion (C): 9,777,000 · Conversion (C): 9,777 (derivative)EDGAR
2025-03-124New Enterprise Associates 15, L.P. — 10% owner
NEA Partners 15, L.P. — 10% owner
NEA 15 GP, LLC — 10% owner
BASKETT FOREST — 10% owner
Florence Anthony A. Jr. — 10% owner
Makhzoumi Mohamad — 10% owner
SANDELL SCOTT D — 10% owner
Conversion (C): 3,333,000 · Conversion (C): 3,333 (derivative)EDGAR
2025-03-124BAYER HEALTHCARE LLC — 10% owner
Bayer US Holding LP — 10% owner
Bayer World Investments B.V. — 10% owner
BAYER AKTIENGESELLSCHAFT — 10% owner
Conversion (C): 2,222,000 · Conversion (C): 2,222 (derivative)EDGAR
2025-03-114Schulz Fran — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-114COOPERSTONE BRENDA — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-114Hsiung Feng — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-114Tang Donald F — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-114Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Conversion (C): 33,000 @ $2.25 · Conversion (C): 33 (derivative) @ $2,250EDGAR
2025-03-114Cross John Harry III — Chief Financial OfficerGrant/award (A): 174,200 (derivative) @ $0EDGAR
2025-03-114Collins James J. — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-114Mathers Edward T — DirectorGrant/award (A): 43,900 (derivative) @ $0EDGAR
2025-03-104Lu Timothy K — CEO and Interim PFO and PAO, DirectorGrant/award (A): 642,358 @ $0 · Grant/award (A): 1,927,073 (derivative) @ $0EDGAR
2025-03-104Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Grant/award (A): 78,363 @ $0 · Grant/award (A): 235,088 (derivative) @ $0EDGAR
2025-02-064Lu Timothy K — CEO, DirectorSale (S): 3,922 @ $4.07 · Sale (S): 545 @ $4.36EDGAR
2025-02-064Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Sale (S): 1,297 @ $4.07 · Sale (S): 182 @ $4.37EDGAR
2024-12-114BAYER HEALTHCARE LLC — 10% owner
Bayer US Holding LP — 10% owner
Bayer World Investments B.V. — 10% owner
BAYER AKTIENGESELLSCHAFT — 10% owner
Purchase (P): 2,222 (derivative) · Purchase (P): 3,333,000 (derivative)EDGAR
2024-12-104Schulz Fran — DirectorGrant/award (A): 12,500 (derivative) @ $0EDGAR
2024-12-104Tang Donald F — DirectorGrant/award (A): 12,500 (derivative) @ $0EDGAR
2024-12-104Rajangam Kanya — Pres. & Chief Med. & Dev. Off.Grant/award (A): 33 (derivative) @ $2,250 · Grant/award (A): 49,500 (derivative) @ $0EDGAR
2024-07-124COOPERSTONE BRENDA — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2024-07-124Collins James J. — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2024-07-124Farokhzad Omid — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2024-07-124Mathers Edward T — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2024-02-024KNOBELMAN DEBORAH — Chief Financial OfficerGrant/award (A): 101,000 @ $0 · Grant/award (A): 152,000 (derivative) @ $0EDGAR
2024-02-024Lu Timothy K — CEO and President, DirectorGrant/award (A): 306,000 @ $0 · Grant/award (A): 459,000 (derivative) @ $0EDGAR
2024-02-024Rajangam Kanya — Chief Medical & Devt. OfficerGrant/award (A): 101,000 @ $0 · Grant/award (A): 152,000 (derivative) @ $0EDGAR
2023-06-214COOPERSTONE BRENDA — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2023-06-214Collins James J. — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2023-06-214Farokhzad Omid — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2023-06-214Mathers Edward T — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2023-06-214Berland Susan D — DirectorGrant/award (A): 62,500 (derivative) @ $0EDGAR
2023-02-024Lee Philip J — Chief Technology OfficerGrant/award (A): 195,000 (derivative) @ $0EDGAR
2023-02-024KNOBELMAN DEBORAH — Chief Financial OfficerGrant/award (A): 130,000 (derivative) @ $0EDGAR
2023-02-024Lu Timothy K — CEO and President, DirectorGrant/award (A): 630,000 (derivative) @ $0EDGAR
2023-02-024Rajangam Kanya — Chief Medical & Devt. OfficerGrant/award (A): 130,000 (derivative) @ $0EDGAR
2022-10-044KNOBELMAN DEBORAH — Chief Financial OfficerGrant/award (A): 30,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0EDGAR
2022-07-204Rajangam Kanya — Chief Medical & Devt. OfficerGrant/award (A): 327,750 (derivative) @ $0EDGAR

Recent 8-K events — Senti Biosciences Holdings, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K4.01 — Changes in Registrant's Certifying Accountant
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-188-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-108-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
EDGAR
2026-10-268-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-10-138-K8.01 — Other EventsEDGAR
2026-09-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-048-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-028-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SNTI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs